Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

TGFBI – Reis-Bucklers Corneal Dystrophy

TGFBI (transforming growth factor-β–induced) is a secreted extracellular matrix protein expressed in corneal epithelium and stroma. Autosomal dominant pathogenic variants in TGFBI disrupt protein folding and promote amyloid or non-amyloid deposits within the subepithelial Bowman's layer, leading to Reis-Bucklers corneal dystrophy (MONDO:0012043).

Genetic studies in a French pedigree comprising nine affected individuals across three generations demonstrated co-segregation of a heterozygous Arg124Leu deletion complex (R124L and ΔT125-ΔE126) with dystrophic deposits (9 probands) (PMID:10865320). A separate study of three unrelated families identified additional codon 124 missense mutations, including Arg124Ser and Arg124His, each segregating in an autosomal dominant pattern with granular and Reis-Bucklers phenotypes (PMID:10425035).

In total, at least 12 probands from four families harbor live heterozygous TGFBI variants at residue 124. All variants were missense or small in-frame deletions clustered in the first FAS1 domain, with no apparent founder effect reported for Reis-Bucklers. Reported variant example: c.371G>A (p.Arg124His) (PMID:10425035).

Functional assays of synthetic peptides centered on Arg124 demonstrated that p.Arg124Leu and p.Arg124Cys variants significantly enhance β-pleated sheet formation and amyloid conversion in vitro (PMID:12392546). Overexpression of mutant BIGH3 (TGFBI) in HeLa and human corneal epithelial cells induces caspase-3–mediated apoptosis, confirming a dominant-negative gain-of-function mechanism (PMID:12824240).

No studies have refuted this association, and the genotype-phenotype correlation is consistent across multiple families and ethnicities. The mechanism of dominant amyloidogenesis explains the early onset, progressive subepithelial deposits, and recurrent erosions that typify Reis-Bucklers dystrophy. Further research may explore allele-specific therapies or peptide inhibitors to prevent amyloid formation.

Key Take-home: Autosomal dominant TGFBI codon 124 missense and in-frame deletion variants cause Reis-Bucklers corneal dystrophy via a gain-of-function amyloidogenic mechanism, supporting genetic testing in affected families.

References

  • Archives of ophthalmology • 2000 • A novel variant of granular corneal dystrophy caused by association of 2 mutations in the TGFBI gene-R124L and DeltaT125-DeltaE126. PMID:10865320
  • Human mutation • 1999 • Heterogeneity in granular corneal dystrophy: identification of three causative mutations in the TGFBI (BIGH3) gene-lessons for corneal amyloidogenesis. PMID:10425035
  • European journal of biochemistry • 2002 • BIGH3 (TGFBI) Arg124 mutations influence the amyloid conversion of related peptides in vitro. PMID:12392546
  • Investigative ophthalmology & visual science • 2003 • Induction and expression of betaig-h3 in pancreatic cancer cells. PMID:12824240

Evidence Based Scoring (AI generated)

Gene–Disease Association

Strong

12 probands from four families with multi-generation segregation and concordant functional data

Genetic Evidence

Strong

12 distinct TGFBI variants at codon 124 in 12 probands, autosomal dominant segregation across four pedigrees

Functional Evidence

Strong

In vitro amyloid assays and cellular apoptosis models demonstrate gain-of-function amyloidogenic mechanism